EUVIMEDEUVIMED entdecken
Crossref

Salvianolic Acid A Protects Against Angiotensin II‐Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF‐κB Pathway

Wenhan Wang iD, Ji Zhang, Jianghua Zhou, Zhenyang Cao, Qianrong Zheng, Pan Huang, Peipei Huang, Jinfu Qian, Xiaokai Ding iD, Chaosheng Chen iD

Molecular Nutrition & Food Research · 2026

DOI: 10.1002/mnfr.70371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2026. Verfasst von Wenhan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Caffeic Acids, Lactates, Nephritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Wenzhou Science Technology Bureau Foundation, Key Laboratory of Intelligent Treatment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertensive nephropathy (HN), a significant consequence of chronic hypertension, remains a leading contributor to end‐stage renal disease. Excessive Angiotensin II (Ang II)–driven inflammation, apoptosis, and fibrosis are central to its pathogenesis. Salvianolic acid A (SAA), a polyphenolic compound from Salvia miltiorrhiza , has anti‐inflammatory properties, but its therapeutic potential in HN is unclear. HN was induced in mice by continuous subcutaneous infusion of Ang II (1.44 mg/kg/day) for 28 days. SAA (10 or 20 mg/kg/day) was administered orally every day during the final 14 days. Network pharmacology suggested SAA targets the TLR4/PI3K/AKT/NF‐κB pathway. SAA administration improved renal function and attenuated inflammatory infiltration, tubular cell apoptosis, and interstitial fibrosis, independent of systemic blood pressure. NRK‐52E cells were used in vitro. SAA inhibited PI3K and AKT phosphorylation, suppressed NF‐κB P65 activation, and downregulated pro‐inflammatory cytokines. The PI3K activator 740 Y‐P abolished these effects. Pull‐down, DARTS assays and molecular docking showed interaction between SAA and TLR4, while TLR4 overexpression reversed SAA's protective actions. These findings provide the evidence that SAA exerts protective effects against Ang II‐induced HN, acting through inhibition of the TLR4/MyD88/PI3K/AKT/NF‐κB axis and represents a potential TLR4‐targeted therapy for hypertensive kidney injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Caffeic AcidsLactatesNephritisHypertension, RenalAnimalsAngiotensin IIMyeloid Differentiation Factor 88Proto-Oncogene Proteins c-aktNF-kappa BSignal TransductionMalePhosphatidylinositol 3-KinasesMiceCell LineMice, Inbred C57BLRatsKidney

Stichwörter der Autor:innen

NF‐κBPI3K/AKTTLR4hypertensive nephropathyinflammationsalvianolic acid A

Substanzen

Toll-Like Receptor 4Angiotensin IIsalvianolic acid AMyeloid Differentiation Factor 88Proto-Oncogene Proteins c-aktNF-kappa BCaffeic AcidsPhosphatidylinositol 3-KinasesLactatesTlr4 protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Institute of Chronic Kidney Disease, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • College of Nursing, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Provincial, Wenzhou, Zhejiang, China.

ORCID-Profile: Wenhan Wang, Xiaokai Ding, Chaosheng Chen

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Wenzhou Science Technology Bureau Foundation
  • Key Laboratory of Intelligent Treatment

Zitieren

APA

Wang, W., Zhang, J., Zhou, J., Cao, Z., Zheng, Q., Huang, P., Huang, P., Qian, J., Ding, X., & Chen, C. (2026). Salvianolic Acid A Protects Against Angiotensin II‐Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF‐κB Pathway. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70371

Vancouver

Wang W, Zhang J, Zhou J, Cao Z, Zheng Q, Huang P, et al. Salvianolic Acid A Protects Against Angiotensin II‐Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF‐κB Pathway. Molecular Nutrition & Food Research. 2026. doi:10.1002/mnfr.70371

BibTeX
@article{Wang2026,
  author = {Wang, Wenhan and Zhang, Ji and Zhou, Jianghua and Cao, Zhenyang and Zheng, Qianrong and Huang, Pan and Huang, Peipei and Qian, Jinfu and Ding, Xiaokai and Chen, Chaosheng},
  title = {Salvianolic Acid A Protects Against Angiotensin II‐Induced Hypertensive Kidney Disease by Targeting TLR4 and Inhibiting TLR4/Myd88/PI3K/AKT/NF‐κB Pathway},
  journal = {Molecular Nutrition & Food Research},
  year = {2026},
  doi = {10.1002/mnfr.70371}
}
Kostenlos starten →